Yes. Rob Barrow Thanks, Elemer. Operator Thank you. Your next question comes from Patrick Trucchio H.C. Wainwright. Patrick, please go ahead. But you are not examining efficacy based on reduction in depressive symptoms. Francois Brisebois Okay, great. And then in terms of the R&D Day that you mentioned would still be in the second quarter, is that where you plan on sharing more details about your commercialization plans for each product? Or is that kind of at a later time? Rob Barrow I think as we think abo ...